GR3032156T3 - Treatment of human lactation failure. - Google Patents

Treatment of human lactation failure.

Info

Publication number
GR3032156T3
GR3032156T3 GR990403242T GR990403242T GR3032156T3 GR 3032156 T3 GR3032156 T3 GR 3032156T3 GR 990403242 T GR990403242 T GR 990403242T GR 990403242 T GR990403242 T GR 990403242T GR 3032156 T3 GR3032156 T3 GR 3032156T3
Authority
GR
Greece
Prior art keywords
treatment
higf
lactation failure
human
human lactation
Prior art date
Application number
GR990403242T
Other languages
English (en)
Inventor
Peter Gluckman
Stella Ruth Milsom
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of GR3032156T3 publication Critical patent/GR3032156T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Treatment Of Sludge (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
GR990403242T 1990-08-03 1999-12-15 Treatment of human lactation failure. GR3032156T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ23476690 1990-08-03
PCT/SE1991/000503 WO1992002245A1 (en) 1990-08-03 1991-07-19 Treatment of human lactation failure

Publications (1)

Publication Number Publication Date
GR3032156T3 true GR3032156T3 (en) 2000-04-27

Family

ID=19923318

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403242T GR3032156T3 (en) 1990-08-03 1999-12-15 Treatment of human lactation failure.

Country Status (13)

Country Link
US (1) US5276014A (el)
EP (1) EP0652767B1 (el)
JP (1) JP3074302B2 (el)
AT (1) ATE184489T1 (el)
AU (1) AU643073B2 (el)
CA (1) CA2086754C (el)
DE (1) DE69131629T2 (el)
DK (1) DK0652767T3 (el)
ES (1) ES2138960T3 (el)
GR (1) GR3032156T3 (el)
IE (1) IE912345A1 (el)
PT (1) PT98563B (el)
WO (1) WO1992002245A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260309A (en) * 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
CN1174504A (zh) * 1993-11-09 1998-02-25 麦克公司 促进生长激素释放的哌啶、吡咯烷和六氢－1h－吖庚因
WO1996009065A1 (en) * 1994-09-21 1996-03-28 Pharmacia & Upjohn Ab Method of treating hypertension in pregnant mammals
AU4318496A (en) * 1994-12-21 1996-07-10 Auckland Uniservices Limited Enhancement of fetal growth by administration of insulin-likegrowth factor-1(IGF-1)
GR1007178B (el) * 1995-02-22 2011-01-31 Πετρομανωλακης Εμμ. Πρωραιος αγωγος σκαφους με διατομην αεροτομης.
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853833A (en) * 1971-04-27 1974-12-10 Hormone Res Foundation Synthetic human growth-promoting and lactogenic hormones and method of producing same
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
ES2001203A6 (es) * 1985-08-12 1988-05-01 Syntex Inc Procedimiento para preparar el polipeptido factor liberador de la hormona del crecimiento bovina
US4783524A (en) * 1985-09-17 1988-11-08 Monsanto Company Growth factors
CA1299103C (en) * 1986-03-07 1992-04-21 Robert Joseph Collier Method and compositions for increasing mammary parenchyma
IL86102A (en) * 1987-05-11 1994-04-12 Univ Tulane Alkylated growth hormone-releasing peptides and use thereof
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5089473A (en) * 1988-08-29 1992-02-18 Monsanto Company Somatotropin variants and their use

Also Published As

Publication number Publication date
JP3074302B2 (ja) 2000-08-07
DE69131629D1 (de) 1999-10-21
PT98563A (pt) 1992-06-30
US5276014A (en) 1994-01-04
EP0652767A1 (en) 1995-05-17
CA2086754A1 (en) 1992-02-04
ATE184489T1 (de) 1999-10-15
JPH05509329A (ja) 1993-12-22
CA2086754C (en) 2000-08-29
AU643073B2 (en) 1993-11-04
PT98563B (pt) 1999-01-29
DK0652767T3 (da) 2000-04-03
WO1992002245A1 (en) 1992-02-20
AU8510891A (en) 1992-03-02
EP0652767B1 (en) 1999-09-15
IE912345A1 (en) 1992-02-12
DE69131629T2 (de) 2000-03-09
ES2138960T3 (es) 2000-02-01

Similar Documents

Publication Publication Date Title
EP1201241B8 (en) Compositions containing capsaicin or capsaicin analogues and an anesthetic
IE882091L (en) Pharmaceutical compositions comprising sometostatin¹analogues
EP0289314A3 (en) Use of igf-ii in the treatment of bone disorders
GR3036774T3 (en) Compositions containing G-CSF and TNF binding protein.
IL96776A0 (en) Quinolone carboxylic acid-metal ion-acid complexes
GR3025792T3 (en) Use of phosphonates for the treatment of osteoporosis.
MX9701187A (es) Nuevas lactamas naftofusionadas n-substituidas.
ES2138960T3 (es) Tratamiento del fallo de la lactacion humana.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
EP0315118A3 (en) Dna coding for endothelin and use thereof
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
AU6978887A (en) Method and compositions for increasing mammary parenchyma
ES8603270A1 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
GB1507643A (en) 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis
EP0904094A4 (en) TREATMENT OF BONE DISEASES WITH ADRENOMEDULLIN
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
IL85031A (en) Lyophilized aspoxicillin preparation and its manufacture
EP0277419A3 (en) Therapeutic somatostatin analogues
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
AT389114B (de) 7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung
IT1209206B (it) Aralchilamine secondarie farmacologicamente attive e loro sali.